WTC
PCVX icon

WhitTier Trust Company’s Vaxcyte PCVX Stock Holding History

WhitTier Trust Company’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23
Closed -$981 – 1301
2025
Q3 		$981 Hold
23
– – ﹤0.01% 1214
2025
Q2 		$747 Hold
23
– – ﹤0.01% 1376
2025
Q1 		$868 Buy
+23
New +$1.84K ﹤0.01% 1347

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

WhitTier Trust Company's PCVX Position: Q4 2025 in Review

WhitTier Trust Company sold out of Vaxcyte (PCVX) in Q4 2025, closing a stake of 23 shares — an estimated $981 sold.

WhitTier Trust Company first reported a position in PCVX in Q1 2025 and held it in 3 quarters. The position peaked at $981 in Q3 2025. 295 funds tracked by Wall St. Rank hold PCVX as of Q4 2025.

  • WhitTier Trust Company reported no remaining Vaxcyte position as of Q4 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 23 Vaxcyte shares in Q4 2025, an estimated $981.
  • WhitTier Trust Company first reported a position in Vaxcyte in Q1 2025 and held it in 3 quarters.
  • WhitTier Trust Company's Vaxcyte position peaked at $981 in Q3 2025.
  • 295 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2025.

Based on WhitTier Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.